K-PAX Pharmaceuticals is currently conducting research on what we project will become the first FDA approved, by-prescription treatment for Chronic Fatigue Syndrome. If you have Chronic Fatigue Syndrome and live in the San Francisco Bay Area, you may inquire about participating in this clinical trial by calling Anne Lahaderne at 415-381-7655.

(An over-the-counter version is currently available as K-PAX ENERGY. For more information on this product, please click here.)

For information on our K-PAX Canadian Study (The MAINTAIN Study) for people with early HIV infection, which is currently enrolling patients, please click here.

HIV/AIDS Research Program - results published in 2006

K-PAX Immune Support Formula was the micronutrient formula tested in a double-blinded, placebo-controlled clinical trial which demonstrated a positive effect on the immune systems of HIV(+) individuals on antiviral therapy.

Forty HIV-infected patients taking a stable antiviral medication regimen were randomized to either the K-PAX formula or placebo groups. After 12 weeks, the patients taking the K-PAX formula experienced an average 24% increase in their CD4 count compared to no change in the placebo group (P=0.01).

The mean absolute CD4 count also rose significantly by an average of 65 cells after 12 weeks in the micronutrient group versus a 6 cell decline in the placebo group (P=0.029).

This research study was presented at the 2006 World AIDS Conference in Toronto (Abstract #0402). It was also published in the August 15th issue of the Journal of Acquired Immune Deficiency Syndromes (JAIDS) - Kaiser JD, et al. JAIDS 2006;42(5):523-528.

To download a copy of this study directly  from the Journal of AIDS website click here

K-PAX is a dietary supplement and is not indicated for the diagnosis, prevention, or treatment of any medical condition. Individual results may vary.